Sun Pharma's Q4 net profit fell 19% to Rs 2,149.8 crore due to input costs and US sales dip while FY25 profit rose 14% with strong domestic growth and specialty push

Sun Pharmaceutical I.. has an average target of 2054.00 from 8 brokers.

Sun Pharma Board Declares Dividend Of Rs 5.5 Per Share Check Record Date

NDTV Profit | 22 May 2025, 05:47PM 2 more

Sun Pharmaceutical Industries Ltd.

22 May 2025, 08:36PM

1718.70

-0.76%

Sun Pharma to seek commercialisation partner for one of its specialty products

Business Line

Recent US directives still in need of clarity, says CMD

Promoters pledged 0.19% of shares in last quarter. Total pledge stands at 0.88% of promoter holdings

Sun Pharmaceutical Industries Ltd.

22 May 2025, 05:31PM

1718.70

-0.76%

to see Rapid results content

Sun Pharmaceutical Industries Ltd.

22 May 2025, 05:29PM

1718.70

-0.76%

Corp. Action

Sun Pharmaceutical Industries Ltd - 524715 - Intimation Of Record Date For The Purpose Of Final …

BSE India

Record date

pdf

Sun Pharmaceutical Industries Ltd.

22 May 2025, 05:18PM

1718.70

-0.76%

Result

Sun Pharmaceutical Industries Ltd - 524715 - Audited Financial Results For The Quarter And Year Ended …

BSE India

Audited Financial Results

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	13571.71	14141.08	12588.84	-4.0%	7.8%
Operating Profit Qtr	3716.09	4009.02	3035.15	-7.3%	22.4%
Net Profit Qtr	2153.93	2912.98	2654.58	-26.1%	-18.9%
Earning Per Share Adjusted latest Qtr	8.98	12.14	11.06	-26.0%	-18.8%